Infliximab as an alternative treatment for Behçet disease when other therapies fail.
Ugras
Meltem
M
Division of Pediatric Gastroenterology, Hepatology and Nutrition, Marmara University School of Medicine, Istanbul, Turkey.
Ertem
Deniz
D
Celikel
Cigdem
C
Pehlivanoglu
Ender
E
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D002648:Child; D003113:Colonoscopy; D005260:Female; D006801:Humans; D000069285:Infliximab; D016896:Treatment Outcome; D014456:Ulcer / Q000188:drug therapy / Q000209:etiology / Q000473:pathology
D000911:Antibodies, Monoclonal; D000069285:Infliximab